Phylogenetic analysis of streptococci in samples taken from the throat cultures of children in Turkey and the presence of mef(A), mef(E), erm(B) and erm(TR) genes in patients with Streptococcus pyogenes

Kirby-Bauer Disk-Diffusion Method

Of the 78 throat culture samples taken from the pediatric patients presenting to our hospital with throat infections in our region, 27 of those belonging to the same patients were excluded, and the remaining 51 were placed in the Cary Blair transport medium using swabs and transferred to the microbiology laboratory. The samples were first inoculated onto blood agar and then kept in an oven for 24 hours, after which the PYR test was applied to beta hemolytic colonies. Using the Kirby-Bauer disk-diffusion method, beta hemolytic bacteria adjusted to 0.5 MacFarland standard were seeded on blood agar, and Cefoxitin, Ciprofloxacin, Levofloxacin, Gentamicin, Amikacin, Netilmicin, Teicoplanin, Vancomycin, Erythromycin, Clindamycin, Tetracycline, Linezolid, Rifampin, Trimethoprim-Sulfamethoxazole, Cefdinir, Cefixime, Cefotaxime and Bacitracin disks were placed on the medium. The susceptibility limits of antibiotics according to the Eucast criteria are given in Table 1 The swabs transported in the Carry Blair transport medium were stored at -80 °C. [11]

Genomic DNA Isolation Protocol

The samples were placed into Eppendorf tubes, to which 200μl dH2O, 50μl 0,5M EDTA, 10μl %20 sarkosyl, 10μl proteinase K (10mg/ml), 10μl 1M Tris-HCl (pH:8), and 5μl 5M NaCl were added. The mixture was vortexed for 5 min and kept in a water bath set at 65 °C for 30 min. During this period, the mixture was vortexed every 10 minutes. Phenol: chloroform: isoamyl alcohol (25:24:1) was added to the cell suspension. It was then centrifuged at 13,000 rpm for 5 min. The supernatant layer was removed with a Pasteur pipette (or a 1,000 μl micropipette the tip of which was cut with a razor blade) and transferred to a new tube. The phenol: chloroform: isoamyl alcohol procedure was performed three times as described above. In each step, the supernatant was removed from the products obtained at the end of centrifugation and transferred to a clean Eppendorf tube, to which 3M NaAc at 1/10 of its volume and absolute ethanol at two times of its volume were added, and this mixture was kept overnight at -20 °C. At the end of this period, the sample was centrifuged at 13,000 rpm for 10 min. The supernatant was removed, and the pellet was dried. After adding 200μl dH2O, the pellet was thawed and 0.3M NaOAc and 440μl ethanol were added at 1/10 volume and kept overnight at -20 °C. At the end of this period, the sample was centrifuged at 13,000 rpm for 5 min. The supernatant was removed, and the pellet was allowed to dry. After drying, the pellet was thawed in 100 µl dH2O. Genomic DNA obtained was examined for quality, RNA contamination and integrity according to the spectrophotometric measurement first, followed by imaging in 0.8% agarose gel. [12]

Gene Sequences used for the Detection of Resistance Genes

In this study, primers containing the following gene sequences were used. [13]

erm(B): f 5’-ATTGGAACAGGTAAAGGGC-3’ and r 5’-GAACATCTGTGGTATGGCG-3’

erm(TR): f5’-ACAGAAAAACCCGAAAAATACG-3’ and r5’ TTGGATAATTTATCAAGATCAG-3’

mef(A): f 5’-TGGTTCGGTGCTTACTATTGT-3’ and r 5’-CCCCTATCAACATTCCAGA-3’

mef(E): f 5’-GGGAGATGAAAAGAAGGAGT-3’ and r 5’-TAAAATGGCACCGAAAG-3’.

Genomic DNA Replication

Genomic DNA was used as source DNA in the PCR reaction. The PCR reaction was established with 16S rRNA (F and R) primers. A solution containing 2.5 µl 10X buffer, 2.5 µl 25 mM MgCl2, 2 µl 2.5 µM dNTP mixtures, 2.5 µl F, 2.5 µl R, 0.5 µl genomic DNA, and 0.2 µl Taq DNA polymerase enzyme (5u/µl) was completed to a total volume of 25 µl by adding 12.3µl ddH2O. The PCR program used for products was as follows: at 94 °C for 2 min, at 94 °C for 1 min, at 55 °C for 1 min, at 72 °C for 1 min, at 72 °C for 4 min, and at 4 °C for ∞.

Agarose Gel Analysis And Gel Imaging

The DNA fragments run in the agarose gel were checked in a UVP transilluminator device, and the data were recorded using a UV-photometer gel documentation device (UviTec).

Purification of PCR Products From Gel

The sizes of the banding formed in the agarose gel in the products as a result of PCR were determined using appropriate markers. The bands suitable for the expected size were removed from the gel. Then, purification was carried out using the QIAquick gel extraction kit and protocol according to the user manual of the kit. The sequence analysis process was performed as required for the determination of purified samples species. The results were evaluated with the BLAST analysis using the NCBI database, and the similarities between the species were determined. A phylogenetic tree was created using CLUSTALW2 and Mega5.

Antibiotic Susceptibility Results

Antibiotic susceptibility was identified in 51 throat swabs taken from pediatric patients presenting to our hospital with throat infections (Table 1).

The antibiotic resistance rates of all streptococcus species were determined as follows: 37% for Cefoxitin, 11% for Netilmicin, 16.2% for Teicoplanin, 24.3% for Erythromycin, 25% for Clindamycin, 13.5% for Tetracycline, 2.7% for Rifampicin, 24.2% for TPM-SXT, 12% for Cefdinir, 22.7% for Ampicillin, and 17% for Penicillin. There was no resistance to Cefixime, Vancomycin, Linezolid, Ciprofloxacin, and Cefotaxime.

Acquisition of Genomic DNA

The genomic DNAs of all bacteria identified in the study were isolated. The DNA concentrations were determined spectrophotometrically, and the working concentration was adjusted. The DNAs obtained as a result of genomic DNA isolation were amplified with primers specific to the 16S rRNA gene regions, and the products formed as a result of PCR were imaged with gel electrophoresis. These products were run in gel electrophoresis, and it was observed that 1300 base pairs were formed, as expected for size. The 16S gene was obtained by PCR. The PCR results of the patient and control groups are shown in Figures 1 and 2, respectively.

• Download figure
• Open in new tab

Figure 1. PCR image of the patient group

• Download figure
• Open in new tab

Figure 2. PCR image of the control group

The sequence analysis was performed on the products obtained by PCR, and as a result, five different Streptococcus species were identified. In Tables 2 and 3, the species identified according to the 16s rRNA analysis are coded with numbers to maintain patient confidentiality.

The species generally identified within the scope of the study were S. pyogenes, Streptococcus pneumoniae, Streptococcus anginosus, Streptococcus agalactiae, and Streptococcus dysgalactiae. A phylogenetic analysis was performed using the results of the sequence analysis. Figure 3 presents the species identified according to the phylogenetic analysis.

• Download figure
• Open in new tab

Figure 3. Results of the phylogenetic analysis of the species

Resistant Gene Regions

In this study, we aimed to determine the penicillin resistance of the identified species. The genetic determinants of macrolide resistance were investigated with the PCR method using primers specific to each of the mef(A), mef(E), erm(B) and erm(TR) genes. Within the scope of the study, it was observed that the expression levels of these genes decreased in some patients (n = 5), and this was considered to be the reason for the lack of response to penicillin and macrolides in these cases (Figure 4).

• Download figure
• Open in new tab

Figure 4. Agarose gel image of the PCR results of the mef(A), mef(E), erm(B) and erm(TR) genes in five patients (Patients 1, 15, 28, 40 and 47) showing resistance

Discussion

GAS is the most common cause of throat infections among bacteria. Both acute and chronic forms of GAS can be seen at the age of three and over; therefore, they are diseases that frequently occur in a wide age group. [14] Contagion occurs with close contact through infected droplets. In addition to domestic transmission, other environments with a high risk of transmission include public areas, such as schools, barracks, and kindergartens. [15] Especially in acute forms, the disease usually spontaneously regresses in a week without the addition of antibiotics to treatment. However, in the presence of severe complications, including acute rheumatic fever and glomerulonephritis, it is recommended to start penicillin treatment without waiting for the culture result, and Hanage et al. stated that resistant strains were developing in patients that did not respond to treatment. [16] Since studies began to be conducted in 1985, growing experience in clinical practice indicates that some patients have resistance against penicillin treatment and that it does not seem beneficial in eradicating Group B streptococci, but this situation cannot be proven in vitro in real life. [17] Examining the results of some antibiotic resistance studies across the world, Erythromycin-resistant S. pyogenes was found in 35% of the children admitted to hospital with throat infections in Italy. [18] Similarly, in France, Erythromycin resistance was reported at a rate of 6.2% in the throat cultures of 1,500 pediatric patients. [19] In our study, the rate of Erythromycin resistance was determined as 9%, which is similar to previous studies. It is also seen that there is gradually increasing macrolide resistance inversely proportional to age, especially among pediatric patients. In a study conducted in Germany, a Group B streptococcus strain that was not susceptible to penicillin was isolated from a single patient. [20] A similar report has not yet been published in Turkey. Examining the in vitro effects of antibiotics, we obtained similar results to the literature concerning the distribution and antibiotic susceptibility of S. pyogenes strains in the pediatric group. [21,22] However, in contrast to previous studies, we also performed a differentiation of strains at the species level in a patient group from our region presenting to our hospital with a sore throat, investigated their antibiotic susceptibility, and determined whether there was any resistance by examining the mef(A), mef(E), erm(B) and erm(TR) genes among the cases that did not respond to penicillin treatment and were suspected to have macrolide resistance.

When the distribution of resistance among our patients was examined, it was observed that resistance to Clindamycin in S. pyogenes was 19% while it reached a higher level (25%) considering all streptococcal species. In a study undertaken by Oryaşin et al., it was reported that the erm B and erm TR genes might have this activity of resistance. [23] In the control group in our study, we observed normal throat flora elements, such as S. agalactiae, S. dysgalactiae, Neisseria spp. Haemophilus spp. and Candida spp.

Globally, there are many studies showing the development of penicillin resistance to Group B streptococci (S. agalactiae). The first S. agalactia resistant to penicillin was reported in 1987, followed by similar reports in many other countries, and the aacA-aphD gene was held responsible for this resistance. [24] To prevent maternal transmission from mother to baby, it is recommended that antibiotic prophylaxis should be applied before normal delivery. [25] Although clear penicillin resistance has not yet been reported for S. pyogenes, macrolides are used as a second option in patients who do not respond to penicillin treatment. [26] In an animal study by Samir et al., penicillin- and macrolide-resistant S. pyogenes was identified, and ermB, one of the resistance genes, was detected in the whole sample. The authors commented that this situation posed a risk of bacterial transmission to humans through children that are in close contact with animals. [27] In another study, Vannice et al. showed the effect of pbp2x point mutation reducing sensitivity to penicillin in a case series of two patients. [28] In our study, resistance genes were found at various expression levels in five patients in a sample of 51 patients. According to the hospital records, our constituted a population that presented to the hospital several times a year due to throat infections. It was observed that the patients in this group did not respond well to macrolide treatment. It is considered that S. pyogenes strains, which have not yet received as much global attention as they require, may gradually become more resistant, to the extent of being described as super-resistant in future. [16]

Some studies have also mentioned the necessity to use secondary treatment options in throat infections that do not respond to penicillin treatment and emphasized how wrong it was to prescribe medicine for pediatric and adult patients by considering their symptoms alone. [29] In the vast majority of studies, macrolide resistance genes were found at various levels. As stated in the literature on this subject, there are various differences between countries even in relation to the structures of resistance genes. [30] In a study conducted in Norway, the mef A gene found in S. pyogenes was observed to differ from that found in S. pneumonia, and this gene was noted to have many subtypes. [31] In another Norwegian study, it was stated that the erm TR gene was present in 26 of 44 Erythromycin-resistant strains, erm B or erm TR in six, and mef E in one. [32] Resistance genes, mechanisms and increased resistance in S. pyogenes, as in all bacteria, cause great economic and moral losses across the world. According to the European Centre for Disease Prevention and Control reports, millions of liras are spent every year for this infection, which easily spreads among children and often requires antibiotic treatment. [33] Nevertheless, there are yet-to-be-proven efficacy problems concerning the first treatment option, penicillin, while at the same time, macrolides, one of the primary alternatives, is also becoming more resistant with each passing day. [34]